Customized diagnostic intelligence for emerging markets

Helping companies make strategic market decisions for clinical diagnostics




Services

Through our custom market intelligence tools and insights, we help companies make better decisions for clinical diagnostics in emerging markets.

Diagno Lab Intel & Analysis

Looking to gather intelligence on potential medical laboratories and diagnostic partners to commercialize and run your product but not sure where to start? With over 1,00,000 commercial laboratories, navigating the diagnostic landscape is a challenge. Diagno Lab Intel & Analysis is a comprehensive bundle of market intelligence tools that provides a holistic view of the laboratory market in India along with insights on key laboratory players and our recommended laboratory partners.

Go Roadshow

Go on a roadshow and meet with different stakeholders along your product value chain to access decision makers and advocacy groups. All stakeholder meetings are set up based on disease focus and industry experience. Meet with physicians, specialists, purchasing managers, diagnostic laboratory experts and others. Market your product, get critical answers, understand buying decisions and establish stakeholder relationships prior to large scale market investments while minimizing risk.

Custom Market Intelligence

Emerging markets represent a key opportunity for growth but also pose a significant challenge. Global strategic initiatives require a concerted effort and understanding of the various dynamics that can influence successful market entry and growth. Each market is unique and requires a customized approach. Innovative BioSolutions can fill this need through customized market intelligence consulting projects. Be it a new market or expanding in existing markets, we can help.











Health Blogs

We attended Precision Genomics Midwest 2018, Cincinnati’s second annual precision genomics conference held on May 11th.
Last week the US Senate held a hearing to discuss the rising cost of insulin; the prices of insulin have trebled in the last few years and one of the factors that were reported was the need for more